Status:

RECRUITING

Identification of New Gene Spliceosomes in Neuroblastoma

Lead Sponsor:

Affiliated Hospital of Nantong University

Conditions:

Neuroblastoma

Eligibility:

All Genders

1-14 years

Brief Summary

Neuroblastoma is an early childhood embryonic malignancy that originates from neural crest cells. Neuroblastoma shows high heterogeneity in biological, morphological, genetic, and clinical features. A...

Detailed Description

The clinical trial study aims to screen the genotype of children with neuroblastoma and conduct an in-depth analysis of sequencing data and tumor-specific transcripts using technologies--Deep Sequenci...

Eligibility Criteria

Inclusion

  • Children with neuroblastoma range in age from 0 to 14, regardless of gender;
  • Preoperative imaging examinations indicate patient with neuroblastoma;
  • Before postoperative chemotherapy, the patient's physical strength is good. At the same time, the results of white blood cells, neutrophils, hemoglobin, platelets, and other test indicators are all within normal range, which is in line with the treatment conditions of the relevant chemotherapy and immunotherapy;
  • Preoperative pathological examination of the patient reveals neuroblastoma;
  • Patients have no other history of malignant tumors;
  • Patients voluntarily participate and sign informed consent and can comply with the study visit plan and other protocol requirements.

Exclusion

  • Patients who are found to have distant metastasis or ascites on preoperative examination are excluded;
  • Patients with severe liver and kidney dysfunction, as well as those with autoimmune diseases are excluded;
  • Patients with severe cardiovascular disease who can not tolerate general anesthesia are excluded;
  • Patients who have other malignancies or blood disorders are excluded.

Key Trial Info

Start Date :

April 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 31 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06502210

Start Date

April 1 2024

End Date

August 31 2024

Last Update

July 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Affiliated Hospital of Nantong University

Nantong, Jiangsu, China